chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure increased, Dizziness, Dysarthria, Fatigue
Clinical narrative: Blood pressure raised; Felt dizzy; Eyes could not focus; Speaking with a lot difficulty; Body felt very heavy, could not move my body much; Feeling of tiredness; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 19Mar2021 at 16:30 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. The patient medical history included hypertension, allergic to silicone and mix nuts. The patient had anaphylactic to flu vaccine, flu and cold medicines and epinephrine. The patient relevant past drug reactions included slight high blood pressure, dizziness and shaking when treated with cortisone shot and hepatitis B vaccine. Concomitant medications reported as propranolol (MANUFACTURER UNKNOWN), alodipine (MANUFACTURER UNKNOWN), meloxicam (MANUFACTURER UNKNOWN) and tyneol (MANUFACTURER UNKNOWN) taken for unspecified indication from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive other vaccines within four weeks of the vaccination. On 19Mar2021 at 04: 30 PM, the patient blood pressure raised and felt dizzy. Moments after patient felt spaced-out, disoriented, eyes could not focus, speaking with a lot difficulty and body felt very heavy, could not move body much. After 15-30 min, BP went down slightly but the patient body was still not reacting normal. The doctor said feeling of tiredness was normal and sent to home for rest. Around 2 hours after the patient blood pressure was still off at 140/60, while normal is 110/70 with BP meds. For almost 3 hours after vaccination, the patient still felt body heaviness, completely unfocused, not move my body well and could speak lightly with difficulty, but all the while, her mind was sharp and thinking clearly and drank gatorade and felt better and body reacted more normal. The next day the patient still felt body was off and was quieter. The patient did not receive treatment for the event. The events result in emergency room/department or urgent care. On 19Mar2021, the patient was tested negative for SARS-CoV-2.  The clinical outcome of blood pressure raised, body felt very heavy, could not move my body much, dizzy, eyes could not focus, speaking with a lot difficulty and feeling of tiredness was resolving at the time of this report.  No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vision blurred
Clinical narrative: Blood pressure raised; Felt dizzy; Eyes could not focus; Speaking with a lot difficulty; Body felt very heavy, could not move my body much; Feeling of tiredness; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 19Mar2021 at 16:30 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. The patient medical history included hypertension, allergic to silicone and mix nuts. The patient had anaphylactic to flu vaccine, flu and cold medicines and epinephrine. The patient relevant past drug reactions included slight high blood pressure, dizziness and shaking when treated with cortisone shot and hepatitis B vaccine. Concomitant medications reported as propranolol (MANUFACTURER UNKNOWN), alodipine (MANUFACTURER UNKNOWN), meloxicam (MANUFACTURER UNKNOWN) and tyneol (MANUFACTURER UNKNOWN) taken for unspecified indication from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive other vaccines within four weeks of the vaccination. On 19Mar2021 at 04: 30 PM, the patient blood pressure raised and felt dizzy. Moments after patient felt spaced-out, disoriented, eyes could not focus, speaking with a lot difficulty and body felt very heavy, could not move body much. After 15-30 min, BP went down slightly but the patient body was still not reacting normal. The doctor said feeling of tiredness was normal and sent to home for rest. Around 2 hours after the patient blood pressure was still off at 140/60, while normal is 110/70 with BP meds. For almost 3 hours after vaccination, the patient still felt body heaviness, completely unfocused, not move my body well and could speak lightly with difficulty, but all the while, her mind was sharp and thinking clearly and drank gatorade and felt better and body reacted more normal. The next day the patient still felt body was off and was quieter. The patient did not receive treatment for the event. The events result in emergency room/department or urgent care. On 19Mar2021, the patient was tested negative for SARS-CoV-2.  The clinical outcome of blood pressure raised, body felt very heavy, could not move my body much, dizzy, eyes could not focus, speaking with a lot difficulty and feeling of tiredness was resolving at the time of this report.  No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pyrexia, Somnolence
Clinical narrative: Extremely tired; Extremely sleepy; Fever; Nauseous; This is a spontaneous report received from a contactable consumer, the patient. A 43-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 20Mar2021 at 14:30 (at the age of 43 years old) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration in the left arm on 27Feb2021 at 13:00 as single dose for COVID-19 immunisation. The patient previously experienced allergies to food, medications, or other products which is unspecified. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extremely tired, extremely sleepy, fever and nauseous on 20Mar2021 at 12:00. The patient did not receive any treatment for the reported events. The clinical outcome of extremely tired, extremely sleepy, fever and nauseous was not recovered.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: Body aches; Fever (102F); Chills; This is a spontaneous report received from a non-contactable consumer, the patient. A 54 -year-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via an unspecified route of administration in the left arm on 20Mar2021 at 09:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number. EN6198) via an unspecified route of administration in the left arm on 27Feb2021at 09:00 (at the age of 54-years old) as a single dose for COVID-19 immunisation. On 20Mar2021 at 20:00, body temperature was measured and found to be 102-degree Fahrenheit. On 20Mar2021 at 20:00, the patient experienced a fever of 102-degree Fahrenheit, chills and body ache. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome for the events fever, body ache and body aches were recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Flat rash on both arms, across stomach and inner thighs; This is a spontaneous report received from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via an unspecified route of administration on 18Mar2021 at 09:00 (at the age of 70 years) as a single dose for COVID-19 immunisation. Medical history included high cholesterol and hypothyroid for an unknown duration.  It was reported that the patient had same reaction to shingles vaccines a few years ago. The patient past drug history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), trazedone (MANUFACTURER UNKNOWN), thyroxine (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) within 2 weeks of vaccination and unknown if ongoing. The patient had not received any other vaccines within four weeks prior to the vaccination. On 21Mar2021, the patient experienced flat rash on both arms, across stomach and inner thighs. The patient had not received any treatment for the adverse events. The clinical outcome of the event flat rash on both arms, across stomach and inner thighs was not recovered at the time of the report.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence, Vaccination site pain
Clinical narrative: sleepiness; Minor ache at shot site; This is a spontaneous report received from a contactable consumer, the patient. A 54-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in right arm on 19Mar2021 at 14:30 (at the age of 54-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 19Mar2021 at 19:00, the patient experienced minor ache at shot site and mild sleepiness. No treatment was received by the patient for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events vaccination site pain and sleepiness was resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Hyperhidrosis, Pain, Vomiting
Clinical narrative: Diarrhea; Vomiting; Chills; Body aches; Sweating; This is a spontaneous report from a contactable consumer. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration, on 20Mar2021, at 13:30, (at the age of 53 years), on left arm, as a single dose for COVID-19 immunisation. Medical history included EVB and COVID-19.Allergies to medications, food, or other products included penicillin, sulphates, lactose and gluten. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, at 14:30, the patient experienced diarrhea, vomiting, chills, body aches, and sweating. The adverse events were resulted in doctor or other healthcare professional office. Therapeutic measures were taken as a result of adverse event with Zophran, (MANUFACTURER UNKNOWN); fish oil, (MANUFACTURER UNKNOWN); Xanax, (MANUFACTURER UNKNOWN); Tylenol, (MANUFACTURER UNKNOWN). The clinical outcome of diarrhea, vomiting, chills, body aches, and sweating was unknown.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Joint swelling, Musculoskeletal stiffness
Clinical narrative: This is a spontaneous report received from a non-contactable consumer. A 73-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration in the arm left on 02Mar2021 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9265) via an unspecified route of administration on 09Feb2021 (at the age of 73-year-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021 (after getting the second dose of vaccination), the patients left elbow was swollen and stiff. It was reported that events were still persisting as of 21Mar2021. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The clinical outcome of the event swollen elbow and stiff were resolving at the time of the report. No follow-up attempts are needed. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Minor soreness of top of left arm; This is a spontaneous report received from a contactable consumer, the patient. An 87-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on 17Mar2021 at 10:00 (at the age of 87-year-old), as a single dose for COVID-19 immunisation. Medical history included allergies(unspecified). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not tested positive for COVID-19 since having the vaccine. On an unspecified date in Mar2021, the patient experienced minor soreness in the top of the left arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the adverse event. The clinical outcome of the event pain in arm was resolved on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Tenderness
Clinical narrative: Left arm is sore / tender (the arm receiving the shot); Left arm is sore / tender (the arm receiving the shot); This is a spontaneous report from a contactable consumer. A 52-year-old patient of unspecified gender received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the left arm on 20Mar2021 at 11:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 20Mar2021 at 19:00, the patient experienced left arm sore / tender (the arm receiving the shot). Therapeutic measures were taken as a result of reported events and included ADVIL. The events had not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event left arm was sore / tender (the arm receiving the shot) was recovering at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Peripheral swelling, Pruritus
Clinical narrative: Reaction on arm; Itchy; Red; swollen arm; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 11Mar2021 at 11:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to Sulfa, eggs and shellfish. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included VIIBRYD, quetiapine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and spironolactone (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 20Mar2021 at 10:00, the patient had reaction on arm on the ninth day following the vaccine. The patient reported that it was itchy, red and swollen. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events reaction on arm, itchy, red and swollen was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Vomiting
Clinical narrative: Nausea; vomiting about 3-4 days after vaccination; Fatigue; This is a spontaneous report received from a non-contactable consumer, the patient. A 21-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 at 13:00 (at the age of 21-years-old) as a single dose, for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication included Aller-Zyr (as reported), diphenhydramine (Benadryl), fluoxetine (MANUFACTURER UNKNOWN) for an unknown indication received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 15Mar2021 at 22:00, the patient had experienced nausea, vomiting about 3-4 days after vaccination and fatigue as well. The patient did not receive any treatment for the reported events. Adverse events resulted in in doctor or other healthcare professional office or clinic visit. The clinical outcome of the events nausea, vomiting about 3-4 days after vaccination and fatigue was resolved on an unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Burning sensation, Headache, Myalgia, Oropharyngeal pain
Clinical narrative: Swollen tongue; burning sensation of tongue; tingling on the entire tongue; small bumps on the side of tongue; slight headach; mild body weakness; Sore throat; mild muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 36-Year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER 8727) via an unspecified route of administration on 19Mar2021 at 14:30 on the left arm as a single dose for COVID-19 immunisation. No known medical history No concomitant medication was not provided. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, the patient experienced swollen, burning sensation and tingling on the entire tongue; small bumps on the side of tongue, progressively worst on the very back; mild, sore throat; very slight headache and mild body weakness. No treatment was received for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of of the events swollen, burning sensation and tingling on the entire tongue; small bumps on the side of tongue, progressively worst on the very back; mild, sore throat; very slight headache; mild body weakness with mild muscle aches was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Swollen tongue, Tongue disorder
Clinical narrative: Swollen tongue; burning sensation of tongue; tingling on the entire tongue; small bumps on the side of tongue; slight headach; mild body weakness; Sore throat; mild muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 36-Year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER 8727) via an unspecified route of administration on 19Mar2021 at 14:30 on the left arm as a single dose for COVID-19 immunisation. No known medical history No concomitant medication was not provided. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, the patient experienced swollen, burning sensation and tingling on the entire tongue; small bumps on the side of tongue, progressively worst on the very back; mild, sore throat; very slight headache and mild body weakness. No treatment was received for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of of the events swollen, burning sensation and tingling on the entire tongue; small bumps on the side of tongue, progressively worst on the very back; mild, sore throat; very slight headache; mild body weakness with mild muscle aches was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Blood test, Chest X-ray, Computerised tomogram
Clinical narrative: Incredibly weak; unsteady on feet; 6cm mass on neck; rash on legs; now food all tastes metallic; This is a spontaneous report received from a contactable consumer, the patient. An 89-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown), via an unspecified route in the right arm on 11Feb2021 at 09:00 as a single dose (at the age of 89-years-old) for COVID-19 immunisation. Medical history included benign prostate hypertrophy. The patient had no known allergies. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient had been tested for COVID-19 after vaccination. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) and prostate pill (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. On 19Feb2021 at 14:00, the patient experienced incredibly weak, was unsteady on feet, had a 6cm mass on neck, rash on legs and food tasted metallic. It was reported that the patient was perfectly healthy prior to vaccine and had a great appetite prior. The events resulted in emergency room visit twice and the patient was treated for these events. On an unknown date, the patient underwent lab tests as treatment for events which included blood work, EKG, chest X-ray, urinalysis, CT scan all with normal results. All the testing done in emergency room had been normal except for mass on neck, it was scheduled to have biopsy of neck on 23Mar2021. The doctors suggested that it was all from the vaccine. The clinical outcome of the events incredibly weak, was unsteady on feet, had a 6cm mass on neck, rash on legs and food tasted metallic was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Electrocardiogram, Neck mass, Rash, Urine analysis
Clinical narrative: Incredibly weak; unsteady on feet; 6cm mass on neck; rash on legs; now food all tastes metallic; This is a spontaneous report received from a contactable consumer, the patient. An 89-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown), via an unspecified route in the right arm on 11Feb2021 at 09:00 as a single dose (at the age of 89-years-old) for COVID-19 immunisation. Medical history included benign prostate hypertrophy. The patient had no known allergies. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient had been tested for COVID-19 after vaccination. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) and prostate pill (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. On 19Feb2021 at 14:00, the patient experienced incredibly weak, was unsteady on feet, had a 6cm mass on neck, rash on legs and food tasted metallic. It was reported that the patient was perfectly healthy prior to vaccine and had a great appetite prior. The events resulted in emergency room visit twice and the patient was treated for these events. On an unknown date, the patient underwent lab tests as treatment for events which included blood work, EKG, chest X-ray, urinalysis, CT scan all with normal results. All the testing done in emergency room had been normal except for mass on neck, it was scheduled to have biopsy of neck on 23Mar2021. The doctors suggested that it was all from the vaccine. The clinical outcome of the events incredibly weak, was unsteady on feet, had a 6cm mass on neck, rash on legs and food tasted metallic was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Body temperature increased, Chills, Fatigue
Clinical narrative: Fatigue; Chills; Headache; Muscle pain; joint pain; Temperature 99.2; This is a spontaneous report received from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route administration in the left arm on 10Mar2021 at 10:00 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes 2 (type 2 diabetics) and neuroendocrine tumors in liver. The patient was allergic to sulfa (sulphonamide allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication includes levothyroxine (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); all drugs were started on an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021 at 13:00, the patient experienced fatigue, chills, headache, muscle pain, joint pain and temperature was 99.2 (body temperature increased) (unspecified units). The patient did not receive any treatment for adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events fatigue, chills, headache, muscle, joint pain and temperature 99.2 were not resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Fatigue; Chills; Headache; Muscle pain; joint pain; Temperature 99.2; This is a spontaneous report received from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route administration in the left arm on 10Mar2021 at 10:00 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes 2 (type 2 diabetics) and neuroendocrine tumors in liver. The patient was allergic to sulfa (sulphonamide allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication includes levothyroxine (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); all drugs were started on an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021 at 13:00, the patient experienced fatigue, chills, headache, muscle pain, joint pain and temperature was 99.2 (body temperature increased) (unspecified units). The patient did not receive any treatment for adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events fatigue, chills, headache, muscle, joint pain and temperature 99.2 were not resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face, Tenderness
Clinical narrative: Left side of face tender and swelling; Left side of face tender and swelling; This is a spontaneous report received from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration in the left arm on 12Mar2021 at 08:30 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroid. The patient did not have any allergies to medications, food, or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18Mar2021 at 08:00, the patients left side of face was tender and had swelling. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse event left side of face tender and swelling. The clinical outcomes of the events tenderness and swelling face were not recovered at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Body rash; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route of administration in the right arm on 17Mar2021 at 13:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient was not reported. Concomitant medications included temisartan 80mg (MANUFACTURER UNKNOWN), valacyclovir 1gm (MANUFACTURER UNKNOWN) & citalopram 10mg (MANUFACTURER UNKNOWN), for unknown indications from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9265), via an unspecified route of administration in the left arm on 08Feb2021 at 19:00hours as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 19Mar2021 at 06:00, the patient experienced body rash. The patient did not receive any treatment for the adverse event. The clinical outcome of the event body rash was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives that lasted for 4 days; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9261), via an unspecified route of administration in the left arm on 16Feb2021 at 09:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation followed by second dose of BNT162b2(PFIZER BIONTECH COVID-19 mRNA VACCINE (lot number: EM9810) via unspecified route of administration on 17Mar2021, as single dose for COVID-19 immunisation. Medical history included high blood pressure, swelling in my legs, allergies, mild asthma, currently having issues with low potassium and sodium. The patient had known allergies to shellfish, codeine, and carmine. The patient received unspecified medication in two weeks of vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Feb2021 at 15:00, the patient experienced I got hives that lasted for 4 days (evenings and overnights mostly) 1 week and 2 days after the first dose. Therapeutic measure was taken as result of event and included treatment with benedryl. Event didn't result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome for event hives was recovered (lasted for 4 days) on an unknown date at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Migraine, Nausea, Vaccination site pain, Vomiting
Clinical narrative: Fatigue; bad headache (migraine type); nausea; vomiting; mild soreness at injection site; This is a spontaneous report from a contactable health care professional, the patient. A 55-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: NDC number: NDC:59267-1000-01(as reported)), via an unspecified route of administration in the left arm on 19Mar2021 at 16:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and seasonal allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not allergic to medication, food and other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications within two weeks of vaccination included Vitamin D and C. The patient experienced fatigue, bad headache (migraine type), nausea, vomiting and mild soreness at injection site on 20Mar2021 at 05:00. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The patient did not receive treatment for reported events. The clinical outcome of fatigue, bad headache (migraine type), nausea, vomiting and mild soreness at injection site was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Disturbance in attention, Frequent bowel movements
Clinical narrative: 3 bowel movements in 8 hours; Unfocused Mind; This is a spontaneous report received from a contactable consumer, the patient. A 57-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in right arm on 20Mar2021 at 09:15 (at the age of 57-years) as a single dose for COVID-19 immunisation. Medical history included obesity, renal insufficiency and fatty liver. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021 at 09:45 (35 minutes after injection), the patient had unfocused mind (easily lost his train of thought) for the duration of 6 hours. On 21Mar2021 (day after injection), the patient was ok in the morning and then had 3 bowel movements in 8 hours. The patient did not experience diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for these events. The clinical outcome of the event unfocused mind was recovered on 21Mar2021 and outcome of the event 3 bowel movements in 8 hours was unknown at the time of this report.   No follow-up attempts are needed. No further information was expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Severe/ Debilitating Backache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 14:15 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. No relevant medical history was reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. Concomitant medications included levothyroxine 100 (MANUFACTURER UNKNOWN), simvastatin 20mg (MANUFACTURER UNKNOWN), allopurinol (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unspecified date in Mar2021 at 15:30, the patient experienced severe / debilitating backache. The patient received ibuprofen as a treatment for the adverse event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe / debilitating backache was resolving at the time of this report.   Information about lot number cannot be obtained. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: I have a rash on the back of my both of my calves.; This is a spontaneous report received from a contactable consumer, the patient. A 41-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) as a single dose via an unspecified route of administration in her right arm on 10Mar2021 at 17:30(at the age of 41-years-old), for COVID-19 immunisation. The patients medical history included diabetes, clotting disorder and history of pulmonary embolism. Concomitant medications included several unspecified medications within two weeks of vaccination. The patient was known allergic to Benadryl. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not tested positive for COVID-19 since having the vaccine. The patient had not diagnosed with COVID-19 prior to vaccination. On 17Mar2021at 00:00 hours, the patient reported as he had a rash on the back of his both of his calves. It appeared 7 days after he was vaccinated. It does not itch much but it does get warm, and he had no other environmental changes or new medications. The patient did not receive treatment for the reported events. The clinical outcome for the event rash was not recovered at the time of this report.  Information about lot number cannot be obtained. No further information is expected
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Neck pain, Photophobia
Clinical narrative: Headache; Neck ache; Aches in all joints; Chills; Unable to sleep; Light sensitivity; This is a spontaneous report received from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 18:15 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Concomitant medications included vitamins, hormones, allergy pills and nose spray. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in the left arm on 27Feb2021 (at the age of 65-years-old) as a single dose for COVID-19 immunisation and experienced headache, neck ache, aches in all joints, chills, unable to sleep and light sensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 03:00, the patient experienced headache, neck ache, aches in all joints, chills, unable to sleep and light sensitivity. Therapeutic treatment taken for the reported events included tylenol and alieve. The clinical outcome of the events headache, neck ache, aches in all joints, chills, unable to sleep and light sensitivity was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Poor quality sleep
Clinical narrative: Headache; Neck ache; Aches in all joints; Chills; Unable to sleep; Light sensitivity; This is a spontaneous report received from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 18:15 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Concomitant medications included vitamins, hormones, allergy pills and nose spray. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in the left arm on 27Feb2021 (at the age of 65-years-old) as a single dose for COVID-19 immunisation and experienced headache, neck ache, aches in all joints, chills, unable to sleep and light sensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 03:00, the patient experienced headache, neck ache, aches in all joints, chills, unable to sleep and light sensitivity. Therapeutic treatment taken for the reported events included tylenol and alieve. The clinical outcome of the events headache, neck ache, aches in all joints, chills, unable to sleep and light sensitivity was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, SARS-CoV-2 test
Clinical narrative: Dizziness most of the time specially at night; This is spontaneous report from a contactable other healthcare professional, the patient. A 43-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration in the left arm, on 17Mar2021 at 07:00, (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent lab tests and procedures, which included COVID-19 test on 08Oct2020, and the result was negative; nasal swab test on 07Nov2020 and the result was negative. Since the vaccination in 2021, the patient was tested for COVID-19  and the result was negative. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine.  On 18Mar2021 at 00:00, the patient experienced dizziness, it was there most of the time especially at night. The patient did not receive any treatment for the event. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of dizziness most of the time specially at night was not resolved at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, SARS-CoV-2 test, Sensory loss
Clinical narrative: Minor sensation loss; Cold feeling right side of face, including around R eye, R mouth corner, R back of throat and tongue; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: PAA156051) via an unspecified route of administration on right arm on 20Mar2021 (at the age of 66 years old) at 07:15, as a single dose for COVID-19 immunisation. Medical history included high BP, cholesterol, osteoporosis, and sensory stroke from an unspecified date in Mar2020 (the patient was fully recovered). The patient was allergic to dust mites, and drugs erythromycin and dicloxacillin. Concomitant medication included unspecified medication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 08:00, the patient experienced minor sensation loss, and cold feeling on the right side of face, including around right eye, right mouth corner, right back of throat and tongue. The patient underwent COVID-19 virus test on an unspecified date and the result was negative. No therapeutic measures were given for the events of sensory loss and cold feeling. The clinical outcome of sensation loss and cold feeling was recovered 4-5 hours later on 20Mar2021. No follow-up attempts are needed. No further information is expected.